GET THE APP

Inhibitory effects of Blackstonia grandiflora extracts on the formation of advanced glycation end products (AGEs) | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Inhibitory effects of Blackstonia grandiflora extracts on the formation of advanced glycation end products (AGEs)

Author(s): Fatima Zohra Belfadela, Kamel Medjroubia, Salah Akkala, Séverine Derbréb and Elisabeth Seguinc

Glycation, the nonenzymatic reaction of reducing sugars with amino groups, is increased in hyperglycemic physiological environments, leading to an acceleration of the formation of advanced glycation end products (AGEs). The AGEs are associated with many pathogenic disorders such as Alzheimer’s disease, pathogenesis of diabetes, and atherosclerosis. They are also responsible for aging and tissue damage. In this study, the antiglycation activity of the extracts Blackstonia grandiflora (Viv.) was evaluated in the bovine serum albumin (BSA)/ribose system and the potency of these extracts was compared with the standard antiglycation agent aminoguanidine. The results showed that EtOAc extract had a significant inhibitory effect on the formation of advanced glycation end products (AGEs).


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry